Erythropoietin and Acute Renal Failure

23Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The hemopoietic growth factor erythropoietin (EPO) has been recognized to be a multifunctional cytokine that plays a key role in ischemic preconditioning in the brain and heart. The EPO receptor is expressed widely in the kidney, and we review the important findings from the use of EPO in experimental models of acute renal failure that show that EPO reduces tubular cell death and hence the dysfunction induced by ischemia reperfusion injury, and we explore how these observations may be translated into the clinical arena. © 2006 Elsevier Inc. All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Sharples, E. J., & Yaqoob, M. M. (2006). Erythropoietin and Acute Renal Failure. Seminars in Nephrology, 26(4), 325–331. https://doi.org/10.1016/j.semnephrol.2006.05.010

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free